drugset / Trial / NCT02849860

Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris

NCT02849860

Phase 1 Completed 20 enrolled Bausch Health Americas, Inc.
NaSingle-groupOpen-labelTreatment

Summary

Open-Label study designed to assess the safety and plasma PK of tretinoin and relevant metabolites after topical dermal application of IDP-121 lotion.

Timeline

Start
2014-02
Primary completion
2016-09
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Tretinoin Small molecule Topical

Indications